CIK 0001727196 · Non-accelerated filer
Scholar Rock Holding Corp
Sign in to watch- Ticker
- SRRK
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 823750435
- Phone
- 857-259-3860
- Business address
- 301 BINNEY STREET, 3RD FLOOR, CAMBRIDGE, MA, 02142
- Open-market buys, last 90 days
- $11,999,922
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$11,999,922. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-03-24 | Moore Erin Interim PFO and PAO | Option exercise 10b5-1 | +8,564 | $13.52 | $116K | 96,173 |
| 2025-03-24 | Moore Erin Interim PFO and PAO | Sale 10b5-1 | −13,564 | $33.12 | $449K | 82,609 |
| 2025-03-24 | Moore Erin Interim PFO and PAO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −5,000 | 11,764 | ||
| 2025-03-24 | Moore Erin Interim PFO and PAO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −8,564 | 40,724 | ||
| 2025-03-17 | Peng Katie Director | Sale 10b5-1 | −1,006 | $34.42 | $35K | 30,319 |
| 2025-03-10 | Qatanani Mo CHIEF SCIENTIFIC OFFICER | Grant or award | +32,145 | 143,229 | ||
| 2025-03-10 | Qatanani Mo CHIEF SCIENTIFIC OFFICER | Grant or award · Stock Option (Right to Buy) | +42,855 | 42,855 | ||
| 2025-03-10 | Parlavecchio Caryn CHRO | Grant or award | +23,570 | 163,828 | ||
| 2025-03-10 | Parlavecchio Caryn CHRO | Grant or award · Stock Option (Right to Buy) | +31,430 | 31,430 | ||
| 2025-03-10 | Marantz Jing L. CHIEF MEDICAL OFFICER | Grant or award | +34,285 | 101,485 | ||
| 2025-03-10 | Marantz Jing L. CHIEF MEDICAL OFFICER | Grant or award · Stock Option (Right to Buy) | +45,715 | 45,715 | ||
| 2025-03-10 | Backstrom Jay T. CHIEF EXECUTIVE OFFICER | Grant or award | +113,570 | 425,561 | ||
| 2025-03-10 | Backstrom Jay T. CHIEF EXECUTIVE OFFICER | Grant or award · Stock Option (Right to Buy) | +151,430 | 151,430 | ||
| 2025-03-10 | Ho Junlin GENERAL COUNSEL | Grant or award | +32,145 | 221,440 | ||
| 2025-03-10 | Ho Junlin GENERAL COUNSEL | Grant or award · Stock Option (Right to Buy) | +42,855 | 42,855 | ||
| 2025-03-10 | Sacco Tracey Chief Commercial Officer | Grant or award | +27,855 | 73,250 | ||
| 2025-03-10 | Sacco Tracey Chief Commercial Officer | Grant or award · Stock Option (Right to Buy) | +37,145 | 37,145 | ||
| 2025-03-10 | Myles Edward H COO & CFO | Option exercise 10b5-1 | +21,690 | $13.83 | $300K | 162,430 |
| 2025-03-10 | Myles Edward H COO & CFO | Option exercise 10b5-1 | +43,122 | $18.08 | $780K | 205,552 |
| 2025-03-10 | Myles Edward H COO & CFO | Option exercise 10b5-1 | +24,915 | $4.86 | $121K | 230,467 |
Page 10 of 12 · 227 trades